publication date: Apr. 28, 2017

In Brief

SU2C awards $1 million to four research teams through Phillip A. Sharp Awards

Stand Up To Cancer awarded $1 million to four teams of cancer researchers to advance “innovation in collaboration” among SU2C-affiliated scientists.

Each team, consisting of researchers from different SU2C-supported “Dream Teams” or research programs who have not previously worked together, will receive a grant of $250,000 over two years to support new research projects stemming from previous advances in cancer research from the SU2C community.   

“Stand Up To Cancer works to break down the barriers to innovation by encouraging collaboration among the best researchers in order to advance science and benefit cancer patients,” said Phillip Sharp, chair of SU2C’s Scientific Advisory Committee and a Nobel Prize winner for his research in genetics. “These teams and their research will help bring us closer to the day we defeat cancer.”

Established in 2014 by SU2C, the Phillip A. Sharp Innovation in Collaboration Awards are intended to reward distinctive collaborations that propose to accelerate current research and development models, bringing therapeutic benefits for cancer patients.

Brief, initial proposals were reviewed by a committee of senior scientists led by SU2C Scientific Advisory Committee co-vice chairs Arnold Levine, professor emeritus of systems biology at the Institute for Advanced Study in Princeton, and William Nelson, director of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. The committee met during the SU2C Scientific Summit in Santa Monica, CA, in January.

Following the summit, each selected team submitted a more detailed, yet still streamlined, two-page proposal and budget to SU2C’s Scientific Advisory Committee.

The award is shared by the following teams: … Continue reading SU2C awards $1 million to four research teams through Phillip A. Sharp Awards

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.